While these AD HIGM2 patients showed a complete impairment of CSR, the impact of pathogenic heterozygous AICDA variants on SHM is variable, with previous studies finding SHM to be unaffected [12, 16, 33] or significantly reduced but detectable [27, 30] in memory B cells from these individuals. Here, AICDA is linked to Alzheimer disease.